Associated Papers
Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Moore A et al.
Medicine, 2021
What's different about atypical CML and chronic neutrophilic leukemia?
Dao KH et al.
Hematology. American Society of Hematology. Education Program, 2015
Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.
Dao KH et al.
Leukemia Research Reports, 2014
Select a paper to view details